2026 SPEAKERS

Kevyn Adler, Senior Director, Market Access Product & Pipeline Strategy, Regeneron

Kevyn Adler | Senior Director, Market Access Product & Pipeline Strategy | Regeneron » speaking at EPA Congress

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & Corporate Affairs | AstraZeneca » speaking at EPA Congress

Tomer Benzaken, Director, Head of Commercial Operations & Trade, Astellas

Tomer Benzaken | Director, Head of Commercial Operations & Trade | Astellas » speaking at EPA Congress

Katja Berg, Global Value and Access Strategy, BBU, AstraZeneca

Katja Berg | Global Value and Access Strategy, BBU | AstraZeneca » speaking at EPA Congress

Angela Borghouts - de Ruijter, Associate Director, Market Access, Gilead Sciences

Angela Borghouts - de Ruijter | Associate Director, Market Access | Gilead Sciences » speaking at EPA Congress

Vidya Breeveld, CEO, Transmineo

Vidya Breeveld | CEO | Transmineo » speaking at EPA Congress

Henriette Burghoorn, Associate Director, Market Access, Gilead

Henriette Burghoorn | Associate Director, Market Access | Gilead » speaking at EPA Congress

Gorana Capkun, Vice President, Global Head of Patient Focused Real World Evidence, Merck Group

Gorana Capkun | Vice President, Global Head of Patient Focused Real World Evidence | Merck Group » speaking at EPA Congress

Antonella Cardone, CEO, Cancer Patients Europe

Antonella Cardone | CEO | Cancer Patients Europe » speaking at EPA Congress

Jag Chhatwal, Director, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School

Jag Chhatwal | Director, Institute for Technology Assessment, Massachusetts General Hospital | Harvard Medical School » speaking at EPA Congress

Sally Chung, Vice President, Value & Access International Operations & Excellence, Ipsen

Sally Chung | Vice President, Value & Access International Operations & Excellence | Ipsen » speaking at EPA Congress

Dalia Dawoud, Associate Director, Research, NICE

Dalia Dawoud | Associate Director, Research | NICE » speaking at EPA Congress

Silvia de Diego Blanco, Director, Global Market Access, Astellas

Silvia de Diego Blanco | Director, Global Market Access | Astellas » speaking at EPA Congress

Jose Diaz, Global Health Systems Economics & Value of Innovation, BMS

Jose Diaz | Global Health Systems Economics & Value of Innovation | BMS » speaking at EPA Congress

Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn

Eva Susanne Dietrich | Professor, Departments for Clinical Pharmacy and Regulatory Affairs | University of Bonn » speaking at EPA Congress

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada | Takeda » speaking at EPA Congress

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at EPA Congress

Marcus Droege, Chief Commercial Officer, MUVON Therapeutics

Marcus Droege | Chief Commercial Officer | MUVON Therapeutics » speaking at EPA Congress

Sara Engstrand, Senior Market Access Manager, Pfizer

Sara Engstrand | Senior Market Access Manager | Pfizer » speaking at EPA Congress

Gina Ewy, Vice President, Head of Global Market Access, Hansa Biopharma

Gina Ewy | Vice President, Head of Global Market Access | Hansa Biopharma » speaking at EPA Congress

Loic Gauthier, Global Pricing Director, CSL Behring

Loic Gauthier | Global Pricing Director | CSL Behring » speaking at EPA Congress

Wim Goettsch, Special Advisor HTA & Professor for HTA of Pharmaceuticals, Zorginstituut & Utrecht University

Wim Goettsch | Special Advisor HTA & Professor for HTA of Pharmaceuticals | Zorginstituut & Utrecht University » speaking at EPA Congress

Thomas Grub, Director, Global Pricing and Market Access, medac GmbH

Thomas Grub | Director, Global Pricing and Market Access | medac GmbH » speaking at EPA Congress

Josep Maria Guiu Segura, Director, Pharmacy and Medicines Area, Consorci de Salut i Social de Catalunya

Josep Maria Guiu Segura | Director, Pharmacy and Medicines Area | Consorci de Salut i Social de Catalunya » speaking at EPA Congress

Steen Werner Hansen, Former Chair Danish Medicines Council, Danish Medicines Council

Steen Werner Hansen | Former Chair Danish Medicines Council | Danish Medicines Council » speaking at EPA Congress

Patrick Hopkinson, Independent HTA Expert

Patrick Hopkinson | | Independent HTA Expert » speaking at EPA Congress

Mohit Jain, Vice President, Market Access, International Operations, IntraBio

Mohit Jain | Vice President, Market Access, International Operations | IntraBio » speaking at EPA Congress

Iroda Jurabekova, Global Director, Oncology Pricing and Market Access, Boehringer Ingelheim

Iroda Jurabekova | Global Director, Oncology Pricing and Market Access | Boehringer Ingelheim » speaking at EPA Congress

Sandeep Kiri, Global Head, Health Economic Evidence, UCB

Sandeep Kiri | Global Head, Health Economic Evidence | UCB » speaking at EPA Congress

Sven Klijn, Director, HEOR Economic & Predictive Modeling, Bristol Myers Squibb

Sven Klijn | Director, HEOR Economic & Predictive Modeling | Bristol Myers Squibb » speaking at EPA Congress

Walmon Leal, Vice President, Head of Global Pricing, Tenders & Contracts, Viatris

Walmon Leal | Vice President, Head of Global Pricing, Tenders & Contracts | Viatris » speaking at EPA Congress

Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, Bristol Myers Squibb

Bill Malcolm | Executive Director, Global HEOR Economic & Predictive Modelling | Bristol Myers Squibb » speaking at EPA Congress

Chris Mancill, Senior Vice President, Head, US Market Access, AstraZeneca

Chris Mancill | Senior Vice President, Head, US Market Access | AstraZeneca » speaking at EPA Congress

Lorenzo Montrasio, Independent Advisor, European commission

Lorenzo Montrasio | Independent Advisor | European commission » speaking at EPA Congress

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at EPA Congress

Helder Mota-Filipe, President, Portuguese Pharmaceutical Association

Helder Mota-Filipe | President | Portuguese Pharmaceutical Association » speaking at EPA Congress

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Secretary General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at EPA Congress

Anh Bourcet Nguyen, Senior Director, Market Access & Public Affairs, APAC, Novo Nordisk

Anh Bourcet Nguyen | Senior Director, Market Access & Public Affairs, APAC | Novo Nordisk » speaking at EPA Congress

Melvin Skip Olson, Founder, Olson Strategies GmbH

Melvin Skip Olson | Founder | Olson Strategies GmbH » speaking at EPA Congress

Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda

Ipek Ozer-Stillman | Vice President, Global Head, Health Economics | Takeda » speaking at EPA Congress

Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics

Michela Pantaleoni | Chief Market Access Officer | Napo Therapeutics » speaking at EPA Congress

Dilip Patel, SVP, Access & Market Development, Autolus

Dilip Patel | SVP, Access & Market Development | Autolus » speaking at EPA Congress

Peter Pemberton-Ross, Head, HE & HTA Strategy, Biogen International GmbH

Peter Pemberton-Ross | Head, HE & HTA Strategy | Biogen International GmbH » speaking at EPA Congress

Annette Powers, Senior Vice President, Global Market Access & HEOR, Bristol Myers Squibb

Annette Powers | Senior Vice President, Global Market Access & HEOR | Bristol Myers Squibb » speaking at EPA Congress

Arup Pramanik, Corporate Vice President, Global Market Access, Boehringer Ingelheim

Arup Pramanik | Corporate Vice President, Global Market Access | Boehringer Ingelheim » speaking at EPA Congress

Jonathan Randell, Head of Value and Access, UK & Ireland, Biogen

Jonathan Randell | Head of Value and Access, UK & Ireland | Biogen » speaking at EPA Congress

Sandra Rose, Head of Market Access & Public Affairs, Chiesi

Sandra Rose | Head of Market Access & Public Affairs | Chiesi » speaking at EPA Congress

Sandy Ruiz, Senior Director, Market Access, Pricing & HEOR, Immunocore

Sandy Ruiz | Senior Director, Market Access, Pricing & HEOR | Immunocore » speaking at EPA Congress

Fabian Schmidt, Global Head of Value, Access & Policy, RECORDATI Rare Diseases

Fabian Schmidt | Global Head of Value, Access & Policy | RECORDATI Rare Diseases » speaking at EPA Congress

Ayman Semaan, Head of Market Access & Pricing, Biologix

Ayman Semaan | Head of Market Access & Pricing | Biologix » speaking at EPA Congress

Hans Severens, Independent HTA Expert, Severens HTA consultancy

Hans Severens | Independent HTA Expert | Severens HTA consultancy » speaking at EPA Congress

Anupama Rao Singh, Vice President, LATAM/Head Oncology COE, Dr. Reddy's Laboratories Ltd.

Anupama Rao Singh | Vice President, LATAM/Head Oncology COE | Dr. Reddy's Laboratories Ltd. » speaking at EPA Congress

Jiri Smejkal, Global Head of Pricing & Tender Excellent for PDT, Takeda

Jiri Smejkal | Global Head of Pricing & Tender Excellent for PDT | Takeda » speaking at EPA Congress

Valentina Strammiello, Director of Strategic Initiatives, European Patients' Forum

Valentina Strammiello | Director of Strategic Initiatives | European Patients' Forum » speaking at EPA Congress

Neeta Tandon, Vice President, Value & Evidence Scientific Engagement, Johnson & Johnson Innovation

Neeta Tandon | Vice President, Value & Evidence Scientific Engagement | Johnson & Johnson Innovation » speaking at EPA Congress

Siguroli Teitsson, Director, GHEOR Economic & Predictive Modeling, Bristol Myers Squibb

Siguroli Teitsson | Director, GHEOR Economic & Predictive Modeling | Bristol Myers Squibb » speaking at EPA Congress

Ilona Torontali, Vice President, Global Pharma Pricing and Reimbursement, Roche

Ilona Torontali | Vice President, Global Pharma Pricing and Reimbursement | Roche » speaking at EPA Congress

Mondher Toumi, Professor of Public Health, Aix-Marseille University

Mondher Toumi | Professor of Public Health | Aix-Marseille University » speaking at EPA Congress

Emmanouil Tsiasiotis, Research Project Manager and Coordinator, EDiHTA

Emmanouil Tsiasiotis | Research Project Manager and Coordinator | EDiHTA » speaking at EPA Congress

Aodan Tynan, Head of Access Implementation, Pricing & Value Demonstration, Astellas

Aodan Tynan | Head of Access Implementation, Pricing & Value Demonstration | Astellas » speaking at EPA Congress

Cristina Valencia, Associate Director, Real World Evidence, Takeda

Cristina Valencia | Associate Director, Real World Evidence | Takeda » speaking at EPA Congress

Chantal van Litsenburg, Manager, Translational Effectiveness, Leiden University Medical Center (Netherlands)

Chantal van Litsenburg | Manager, Translational Effectiveness | Leiden University Medical Center (Netherlands) » speaking at EPA Congress

Reg Waldeck, Vice President, Head Global Market Access, Bayer

Reg Waldeck | Vice President, Head Global Market Access | Bayer » speaking at EPA Congress

Rhys Williams, Vice President, Evidence Generation Strategy and Health Economics, Global Medical Affairs (ex-China), BeiGene

Rhys Williams | Vice President, Evidence Generation Strategy and Health Economics, Global Medical Affairs (ex-China) | BeiGene » speaking at EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com